ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adagene Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$2.29+0.23 (+11.17%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Adagene statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Adagene | Industry median |
|---|---|---|
| Market Cap | $135.64M | $164.85M |
| Enterprise Value | $67.24M | $87.06M |
| PS Ratio | 17.68 | 3.60 |
| PB Ratio | 3.84 | 2.03 |
| P/TBV Ratio | 3.84 | 2.31 |
Enterprise value
| Measure | Adagene | Industry median |
|---|---|---|
| EV / Sales | 8.76 | 2.43 |
Income (trailing twelve months)
| Measure | Adagene | Industry median |
|---|---|---|
| Revenue | $7.67M | $57.94M |
| Operating Income | -$21.44M | -$21.44M |
| Pretax Income | -$17.91M | -$14.45M |
| Net Income | -$17.61M | -$22.46M |
| EBITDA | -$21.00M | -$16.91M |
| EPS (Diluted) | -$0.30 | -$0.83 |
Margins
| Measure | Adagene | Industry median |
|---|---|---|
| Operating Margin | -279.5% | -44.5% |
| Pretax Margin | -233.4% | -13.0% |
| Profit Margin | -229.6% | -39.2% |
| EBITDA Margin | -273.8% | -31.3% |
| FCF Margin | -204.3% | -8.85% |
Returns
| Measure | Adagene | Industry median |
|---|---|---|
| Return on Equity (ROE) | -41.0% | -53.1% |
| Return on Assets (ROA) | -21.0% | -41.0% |
| Return on Capital Employed (ROCE) | -40.4% | -37.8% |
Growth
| Measure | Adagene | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7332.8% | 6.01% |
| Revenue Growth (3Y CAGR) | -6.19% | 2.25% |
| Revenue Growth (5Y CAGR) | 61.4% | 6.42% |
Balance sheet
| Measure | Adagene | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $74.52M | $62.42M |
| Total Debt | $6.12M | $120.13M |
| Net Cash (Debt) | $68.41M | $15.68M |
| Net Cash Per Share | $1.15 | $0.66 |
| Equity (Book Value) | $35.35M | $48.79M |
| Book Value Per Share | $0.60 | $1.36 |
| Tangible Book Value | $35.35M | $23.06M |
| Working Capital | $52.20M | $75.77M |
Financial position
| Measure | Adagene | Industry median |
|---|---|---|
| Current Ratio | 3.07 | 3.30 |
| Quick Ratio | 2.96 | 2.39 |
| Debt / Equity | 0.17 | 0.51 |
| Interest Coverage | -46.29 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Adagene | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.66M | -$12.35M |
| Capital Expenditures | -$17.05K | -$1.06M |
| Free Cash Flow | -$15.67M | -$20.28M |
| FCF Per Share | -$0.26 | -$0.42 |
Efficiency
| Measure | Adagene | Industry median |
|---|---|---|
| Asset Turnover | 0.09 | 0.38 |
| Revenue Per Employee | $59.93K | $398.96K |
| Profits Per Employee | -$137.57K | -$703.34K |
| Employee Count | 128 | 74 |
Dividends and yields
| Measure | Adagene | Industry median |
|---|---|---|
| Earnings Yield | -13.0% | -22.7% |
| FCF Yield | -11.6% | -9.07% |
Shares
| Measure | Adagene | Industry median |
|---|---|---|
| Shares Outstanding | 59,232,000 | 58,179,650 |
| Shares Change (YoY) | 4.83% | 11.1% |
| Float | 49,287,500 | 49,173,100 |
| Shares Held by Insiders | 16.8% | 11.6% |
| Shares Held by Institutions | 32.5% | 59.4% |
Taxes
| Measure | Adagene | Industry median |
|---|---|---|
| Income Tax | -$297.86K | $91.50K |
Scores
| Measure | Adagene | Industry median |
|---|---|---|
| Altman Z-Score | -2.80 | -0.24 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Adagene's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.